Cargando…

Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review

A causal relationship between elevated triglycerides and cardiovascular disease is controversial, as trials of triglyceride-lowering treatments have not shown significant impact on cardiovascular outcomes. However, hypertriglyceridemia is associated with atherogenesis and risk for acute cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toth, Peter P., Shah, Prediman K., Lepor, Norman E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481317/ https://www.ncbi.nlm.nih.gov/pubmed/32929418 http://dx.doi.org/10.1016/j.ajpc.2020.100086

Ejemplares similares

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
por: Makover, Michael E., et al.
Publicado: (2022)

Ten things to know about ten cardiovascular disease risk factors – 2022
por: Bays, Harold E, et al.
Publicado: (2022)

Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia
por: Juul Rasmussen, Ida, et al.
Publicado: (2023)

Ten things to know about ten cardiovascular disease risk factors
por: Bays, Harold E., et al.
Publicado: (2021)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the ASPC Part I: Bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations
por: Franklin, Barry A., et al.
Publicado: (2022)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
por: Vicente, Jose, et al.
Publicado: (2017)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Bias in Medicine: Lessons Learned and Mitigation Strategies
por: Hammond, M. Elizabeth H., et al.
Publicado: (2021)

Cardiovascular risk assessment: The foundation of preventive cardiology
por: Wong, Nathan D.
Publicado: (2020)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease
por: Myers, Valerie D., et al.
Publicado: (2018)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Small non-coding RNA therapeutics for cardiovascular disease
por: Shah, Ajay M, et al.
Publicado: (2022)

Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations
por: Franklin, Barry A., et al.
Publicado: (2022)

Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
por: Arafa, Ahmed, et al.
Publicado: (2021)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction
por: Sikand, Geeta, et al.
Publicado: (2020)

Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets
por: Schultz, Taylor I., et al.
Publicado: (2022)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)

Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review
por: Lee, Choon-Soo, et al.
Publicado: (2022)

The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health
por: Bui, Thi Van Anh, et al.
Publicado: (2023)

Inherited Thoracic Aortic Disease: New Insights and Translational Targets
por: Fletcher, Alexander J., et al.
Publicado: (2020)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
por: Wesley Milks, Michael, et al.
Publicado: (2021)

Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention
por: Elder, Petal, et al.
Publicado: (2020)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten – 2020”)
por: Bays, Harold Edward
Publicado: (2020)

Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians
por: Agarwala, Anandita, et al.
Publicado: (2022)

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Georgiopoulos, Georgios, et al.
Publicado: (2023)

A Cardio-Oncology Cardiovascular Prevention Framework
por: Marvel, Françoise A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5a60dod433k31ibobrpvv9cu6k